Form 4 for AXGN Axogen, Inc.
Accepted 2023-06-05 00:00:00 ET · period of report 2023-06-01 · accession 0000805928-23-000062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-05 | 2023-06-01 | AXGN | Freitag Gregory Gene | Dir | S - Sale+OE | $8.71 | -42.0K | 290.1K | -13% | -$365.8K |
| D | 2023-06-05 | 2023-06-01 | AXGN | Freitag Gregory Gene | Dir | M - OptEx | $0.00 | +6,459 | 296.6K | +2% | $0 |
| D | 2023-06-05 | 2023-06-01 | AXGN | Freitag Gregory Gene | Dir | M - OptEx | $0.00 | -6,459 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-01 | S | D | 12,500 | $8.65 | 319,615 | D | — | — | (F1) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.57 to $8.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-06-01 | S | D | 29,480 | $8.74 | 290,135 | D | — | — | (F2) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.66 to $8.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2023-06-01 | M | A | 6,459 | $0.00 | 296,594 | D | — | — | (F3) This reflects the number of restricted stock units that vested on June 1, 2023. |
| 4 | Derivative | Restricted Stock Units | 2023-06-01 | M | D | 6,459 | $0.00 | 0 | D | — · — to — | 6,459 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F5) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date. |